Indian pharmaceutical and healthcare stocks are trading mixed-to-weak in early trade on April 24, 2026, broadly in line with the broader market. The S&P BSE Sensex is down 0.76% at 77,077.03, and the Nifty 50 is lower by 0.71% at 24,002.45 as of the time of this update.
Data captured from BSE at 9:36 AM and NSE at 9:39 AM shows a majority of pharma and healthcare stocks declining, with a handful of counters posting modest gains.
Notable Gainers
Among the stocks in the green, Emcure Pharmaceuticals is the standout performer, up 2.56% on BSE at ₹1,651.25 and 3.24% on NSE at ₹1,652.90.
Corona Remedies is up 1.31% on BSE (₹1,662.20) and 0.83% on NSE (₹1,658.10). Piramal Pharma is also 1.31% higher on BSE at ₹165.95 (not listed on NSE).
RPG Life Sciences has gained 1.10% on BSE to ₹2,032.70 and 1.37% on NSE to ₹2,039.00. Anthem Biosciences is up 1.36% on BSE at ₹750.65 and 0.66% on NSE at ₹745.55.
Other modest gainers include Indraprastha Medical (+1.24% BSE), Sudeep Pharma (+1.15% BSE), Natco Pharma (+0.96% BSE), Senores Pharmaceuticals (+0.98% BSE), Alkem Laboratories (+0.67% BSE), Divis Laboratories (+0.54% BSE), Ajanta Pharma (+0.54% BSE), Aster DM Healthcare (+0.58% BSE), Max Healthcare (+0.70% BSE), and Advanced Enzyme Technologies (+0.62% BSE).
Notable Losers
Jubilant Industries is the session’s biggest decliner in the pharma space, falling 4.08% on BSE to ₹1,639.05 and 4.46% on NSE to ₹1,633.50.
Windlas Biotech is down 3.08% on BSE (₹868.10) and 3.66% on NSE (₹861.85). Unichem Laboratories has shed 2.59% on BSE and 3.37% on NSE to ₹372.40.
Dishman Carbogen Amcis is lower by 2.23% on BSE at ₹170.70. Pfizer has declined 1.92% on BSE to ₹4,690.45 and 2.02% on NSE to ₹4,686.50. Sun Pharmathe sector’s largest by market cap, is trading 1.72% lower on BSE at ₹1,650.90 and 1.94% lower on NSE at ₹1,647.50.
Bliss GVS Pharma is down 2.06% on BSE and 2.30% on NSE. Sequent Scientific is off 2.08% on BSE. Cipla is 1.30% lower at ₹1,288.90 on BSE. Lupin has lost 0.75% on NSE to ₹2,323.80. Wyeth is down 2.27% on BSE to ₹1,334.60.
Large-Cap Pharma Snapshot
| Stock | BSE Price (₹) | Change | NSE Price (₹) | Change |
|---|---|---|---|---|
| Sun Pharma | 1,650.90 | -1.72% | 1,647.50 | -1.94% |
| Cipla | 1,288.90 | -1.30% | 1,288.60 | -1.32% |
| Dr. Reddy’s | 1,323.90 | -0.69% | 1,325.00 | -0.45% |
| Lupin | 2,331.35 | -0.38% | 2,323.80 | -0.75% |
| Aurobindo Pharma | 1,437.15 | +0.09% | 1,432.00 | -0.24% |
| Divis Labs | 6,413.50 | +0.54% | 6,394.50 | +0.25% |
| Torrent Pharma | 4,132.00 | -0.33% | 4,127.50 | -0.48% |
| Abbott India | 25,330.00 | -0.36% | 25,325.00 | -0.33% |
| Biocon | 355.65 | -0.60% | 355.30 | -0.75% |
| Zydus Lifesciences | 937.20 | -1.05% | 935.15 | -1.18% |
Diagnostics & Hospital Stocks
Healthcare services and diagnostics stocks are also mostly lower. Dr. Lal PathLabs is down 1.11% on BSE to ₹1,415.20. Vijaya Diagnostic has fallen 1.44% on BSE to ₹1,014.70. Metropolis Healthcare is down 1.10% on BSE. Thyrocare is lower by 1.09% on BSE at ₹390.70. Krsnaa Diagnostics is off 0.26% on BSE at ₹609.30.
Among hospital stocks, Max Healthcare is a bright spot, up 0.70% on BSE at ₹1,014.00 and 0.85% on NSE at ₹1,015.30. Aster DM Healthcare is up 0.58% on BSE. KIMS is marginally lower at ₹651.65 on BSE (-0.40%). Shalby is down 1.50% on BSE.
Disclaimer
Prices sourced from BSE (9:36 AM) and NSE (9:39 AM) on April 24, 2026. This article is for informational purposes only and does not constitute investment advice. Stock prices are subject to change. Please verify prices on official exchange platforms before making any financial decisions. Consult a SEBI-registered investment advisor for personalized guidance.
Comments are closed.